Apyx medical corp (APYX)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Sales

28,235

16,605

10,234

-

-

-

-

-

-

-

-

Sales

-

-

-

8,819

29,520

27,681

23,660

27,671

25,411

24,230

26,953

Cost of sales

9,141

5,779

3,276

3,703

16,963

18,689

14,462

16,338

14,680

14,242

15,098

Gross profit

19,094

10,826

6,958

5,116

12,557

8,992

9,198

11,333

10,731

9,988

11,855

Gain on legal settlement

-

-

-

-

-

-

-

-

750

-

-

Other costs and expenses:
Gain on legal settlement

-

-

-

-

-

-

-

-

-

0

0

Research and development

3,700

2,500

1,900

1,033

2,160

1,416

1,260

1,329

1,197

1,854

2,083

Professional services

8,507

3,133

1,769

1,473

1,484

1,016

1,835

1,439

1,250

1,556

1,398

Salaries and related costs

14,025

9,272

6,920

7,817

7,482

5,723

3,992

3,178

3,114

3,155

3,003

Selling, general and administrative

13,700

9,407

8,689

6,185

8,417

6,686

5,777

4,341

4,347

4,889

4,656

Severance and related expense

0

741

1,524

0

0

-

-

-

-

-

-

Total other costs and expenses

39,963

25,102

20,843

16,508

19,543

14,841

-

-

-

-

-

Legal award

-

-

-

-

-

-

-

-

1,591

0

0

Asset impairment

-

-

-

-

-

-

-

-

-

1,286

0

Total other costs and expenses

-

-

-

-

-

-

12,864

10,287

11,499

12,740

11,140

Loss from operations

-20,869

-14,276

-13,885

-11,392

-6,986

-5,849

-3,666

1,046

-18

-2,752

715

Interest income

1,392

616

0

0

-

-

-

-

-

-

-

Interest expense

8

104

136

158

-

-

-

-

-

-

-

Interest income (expense), net

-

-

-

-

-158

-151

-237

-232

-237

-223

-52

Other income (losses), net

-351

-947

0

0

-

-

-

-

-

-

-

Investor warrants issuance cost

-

-

-

-

-

-

-664

0

-

-

-

Fees associated with refinance

-

-

-

-

-

-

-543

0

-

-

-

Issuance cost

-

-

-

-

-

-

-

-

0

-

-

Fees associated with refinance

-

-

-

-

-

-

-

-

0

-

-

Change in value of derivative liabilities

0

20

183

64

1,799

-7,285

-842

20

287

513

0

Total other income, net

1,033

-415

47

-94

1,641

-7,436

-

-

50

290

-52

Total other income (expense), net

-

-

-

-

-

-

2,286

212

-

-

-

Loss before income taxes

-19,836

-14,691

-13,838

-11,486

-5,345

-13,285

-5,952

834

32

-2,462

663

Provision for current income taxes

-

-

-

-

-

-

-

-

0

7

-7

Benefit (provision) for deferred income taxes

-

-

-

-

-

-

-

-

77

-934

-60

Income Tax Expense (Benefit)

-130

-3,907

-156

64

25

3,997

-1,613

217

77

-927

67

Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent

-19,706

-10,784

-13,682

-

-

-

-

-

-

-

-

Income from discontinued operations, net of tax

0

5,099

8,620

7,600

-

-

-

-

-

-

-

Gain on sale of the Core Business, net of tax

0

68,404

0

0

-

-

-

-

-

-

-

Income (loss) from discontinued operations and disposal of discontinued operations, net of tax

0

73,503

8,620

7,600

-

-

-

-

-

-

-

Net income (loss)

-

-

-

-

-

-

-

-

109

-

-

Accretion of preferred shares

-

-

-

-

-

-

-

-

0

-

-

Deemed dividend on beneficial conversion feature

-

-

-

-

-

-

-

-

0

-

-

Net Income (Loss) Attributable to Parent

-19,706

62,719

-5,062

-11,550

-5,370

-17,282

-4,339

617

109

-1,535

596

Accretion on convertible preferred stock

-

-

-

-

-222

-932

-39

-

-

-

-

Gain on conversion of warrants and preferred shares, net

-

-

-

-

13,956

0

0

-

-

-

-

Deemed dividend on beneficial conversion feature

-

-

-

-

-

-

-2,616

0

-

-

-

Net Income (Loss) Available to Common Stockholders, Basic

-

-

-

-3,950

8,364

-18,214

-6,994

617

-

-

-

Earnings Per Share [Abstract]
Basic and diluted (in dollars per share)

-0.58

-0.32

-0.44

-0.42

-

-

-

-

-

-

-

Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share [Abstract]
Basic (in dollars per share)

0.00

2.21

0.27

0.28

-

-

-

-

-

-

-

Diluted (in dollars per share)

0.00

2.14

0.27

0.28

-

-

-

-

-

-

-

EPS from total operations:
Basic (in dollars per share)

-0.58

1.89

-0.16

-0.14

0.34

-1.03

-0.40

0.04

0.01

-0.09

0.04

Basic and Diluted (in dollars per share)

-

-

-

-0.15

-

-

-

-

-

-

-

Diluted (in dollars per share)

-0.58

1.83

-0.17

-

0.24

-1.03

-0.40

0.03

0.01

-0.09

0.03

Weighted Average Number of Shares Outstanding, Basic

34,069

33,185

31,420

27,433

24,333

17,756

17,760

17

17

17,367

16,899

Weighted Average Number of Shares Outstanding, Diluted

34,069

34,366

31,427

27,449

27,747

17,756

17,760

17

17

17,367

-

Weighted average number of shares outstanding - dilutive

-

-

-

-

-

-

-

-

-

-

17,836